33 results on '"Intorcia, M"'
Search Results
2. PCR173 The Geographic Atrophy Long-Term Outcomes Study (GALTOS): Preliminary Analysis of Patient Clinical Characteristics, Retrospective Natural History, and Patient Survey Results
3. PCR112 A Time Trade-Off Study to Develop Health-Related Utility Data for the Impact of Geographic Atrophy on Patients
4. PCR203 A Qualitative Study of the Health-Related Quality of Life Impact of Geographic Atrophy on Patients
5. MSR18 Modelling Challenges in Geographic Atrophy
6. EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States
7. POSA29 A New Patient-Focused Progression Model for Geographic Atrophy
8. PUK6 A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE
9. PUK3 TREATMENT EFFECTS IN SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW
10. PHS32 - Incremental Healthcare Resource use and Costs Associated with Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors
11. PCN7 - Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer
12. PCN31 - Occurrence Of Skeletal-Related Events (SRE) In Patients With Solid Tumors (ST) And Multiple Myeloma (MM) In Germany: Early Versus Late Initiation of Sre Preventative Agents (SPA)
13. PCN11 - Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM): A Patient Chart Audit In EU5
14. PCN287 - Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM): Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom
15. PCN44 - Prevalence Of Renal Impairment In Patients With Multiple Myeloma: Analysis Of Real-World Database
16. PMS132 - Grand-4: The German Retrospective Analysis on Persistence in Women with Osteoporosis Treated with Bisphosphonates or Denosumab
17. PMS92 - Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria
18. PMS63 - Systematic Review and Meta-Analysis of Persistence With Denosumab in Patients With Osteoporosis
19. PMS32 - The Cost of Osteoporotic Fractures in the Romanian Postmenopausal Women Population
20. PMS56 Impact of Compliance on Fracture Risk for Osteoporosis in Postmenopausal Women in Hungary
21. PMS54 A Retrospective Cohort Study of Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary
22. PMS55 A Retrospective Cohort Study of Persistence & Compliance to Treatment for Osteoporotic Men in Hungary
23. PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece
24. PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece
25. PIH30 PERSISTENCE TO POSTMENOPAUSAL OSTEOPOROSIS (PMO) TREATMENTS IN A REGION OF SPAIN
26. PMS24 OSTEOPOROSIS COSTS IN ITALY. INTERIM RESULTS OF THE BLOCK STUDY
27. PMS68 GRAND: THE GERMAN RETROSPECTIVE COHORT ANALYSIS ON NON-ADHERENCE IN OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATES
28. PMS66 GRAND: THE GERMAN RETROSPECTIVE COHORT ANALYSIS ON NON-ADHERENCE AND ASSOCIATED RISK OF FRACTURES IN OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATES
29. PMS62 DISCONTINUATION RATE OF THE IST AND IIND ANTI-TUMOR NECROSIS FACTORTHERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY
30. PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY: A PROBABILISTIC SENSITIVITY ANALYSIS
31. PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY
32. PIN14 USING A DECISION SIMULATION MODELTO EVALUATE THE COST-EFFECTIVENESS OF THE TREATMENT OF NUCLEOSIDE-NAÏVE HBE-ANTIGEN NEGATIVE CHB PATIENTS IN ITALY WITH ENTECAVIR AND TEN OF OVIR
33. IN1 COST EFFECTIVENESS ANALYSIS OF REYATAZ® VERSUS KALETRA® IN THE TREATMENT OF NAÏVE HIV PATIENTS IN ITALY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.